These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 929152)

  • 1. [Frequent cases of agranulocytosis due to clozapin (leponex) in eastern Switzerland].
    Jungi WF; Fischer J; Senn HJ; Hartlapp J; Pöldinger W; Kunz H; Krupp P
    Schweiz Med Wochenschr; 1977 Dec; 107(49):1861-4. PubMed ID: 929152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agranulocytosis in patients treated with clozapine. A study of the Finnish epidemic.
    Amsler HA; Teerenhovi L; Barth E; Harjula K; Vuopio P
    Acta Psychiatr Scand; 1977 Oct; 56(4):241-8. PubMed ID: 920225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood dyscrasias in clozapine-treated patients in Italy.
    Lambertenghi Deliliers G
    Haematologica; 2000 Mar; 85(3):233-7. PubMed ID: 10702809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine treatment after agranulocytosis induced by classic neuroleptics.
    Bauer M; Mackert A
    J Clin Psychopharmacol; 1994 Feb; 14(1):71-3. PubMed ID: 7908676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clozapine: an exclusive treatment?].
    Vanelle JM
    Encephale; 1992 Sep; 18 Spec No 3():441-5. PubMed ID: 1339761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
    Hägg S; Rosenius S; Spigset O
    Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clozapine (Leponex)].
    Bilikiewicz A; Sulestrowska H
    Psychiatr Pol; 1977; 11(2):251-3. PubMed ID: 887685
    [No Abstract]   [Full Text] [Related]  

  • 8. [Problem of side effects of leponex on blood (multicenter inter- national study)].
    Panteleeva GP; Gamkrelidze ShA; Dikaia VI; Magalif AA; Okuneva TP; Perevozniuk AG; Shtemberg K; Filip V; German E; Zapletanek M
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(10):70-3. PubMed ID: 1665659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hematological complications caused by clozapine (Leponex)].
    Palva I
    Duodecim; 1976; 92(1):1-2. PubMed ID: 1248428
    [No Abstract]   [Full Text] [Related]  

  • 10. Clozapine-induced agranulocytosis: non-cross-reactivity with other psychotropic drugs.
    Lieberman JA; Johns CA; Kane JM; Rai K; Pisciotta AV; Saltz BL; Howard A
    J Clin Psychiatry; 1988 Jul; 49(7):271-7. PubMed ID: 3391979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agranulocytosis during treatment with chlozapine.
    Idänpään-Heikkilä J; Alhava E; Olkinuora M; Palva IP
    Eur J Clin Pharmacol; 1977 Mar; 11(3):193-8. PubMed ID: 856603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine for refractory schizophrenia: an open study of 14 patients treated up to 2 years.
    Mattes JA
    J Clin Psychiatry; 1989 Oct; 50(10):389-91. PubMed ID: 2571612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine-associated agranulocytosis: risk and aetiology.
    Krupp P; Barnes P
    Br J Psychiatry Suppl; 1992 May; (17):38-40. PubMed ID: 1418887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind comparison of clozapine with chlorpromazine in acute schizophrenic illness.
    Chiu E; Burrows G; Stevenson J
    Aust N Z J Psychiatry; 1976 Dec; 10(4):343-7. PubMed ID: 798582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human leukocyte antigen typing, response to neuroleptics, and clozapine-induced agranulocytosis in jewish Israeli schizophrenic patients.
    Meged S; Stein D; Sitrota P; Melamed Y; Elizur A; Shmuelian I; Gazit E
    Int Clin Psychopharmacol; 1999 Sep; 14(5):305-12. PubMed ID: 10529073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine-induced agranulocytosis: a situation report up to August 1976.
    Anderman B; Griffith RW
    Eur J Clin Pharmacol; 1977 Mar; 11(3):199-201. PubMed ID: 852497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hematologic effects of clozapine: evaluation of the international experience].
    Lamarque V
    Encephale; 1995 Jun; 21 Spec No 3():59-60. PubMed ID: 7628344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States.
    Alvir JM; Lieberman JA; Safferman AZ; Schwimmer JL; Schaaf JA
    N Engl J Med; 1993 Jul; 329(3):162-7. PubMed ID: 8515788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine and agranulocytosis.
    Senn HJ; Jungi WF; Kunz H; Pöldinger W
    Lancet; 1977 Mar; 1(8010):547. PubMed ID: 65644
    [No Abstract]   [Full Text] [Related]  

  • 20. Should chronic treatment-refractory akathisia be an indication for the use of clozapine in schizophrenic patients?
    Levin H; Chengappa KN; Kambhampati RK; Mahdavi N; Ganguli R
    J Clin Psychiatry; 1992 Jul; 53(7):248-51. PubMed ID: 1353492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.